Aim: To provide an update of the review by Taylor (Journal of Clinical Periodontology, 2013, 40, S113) regarding the scientific evidence of the biological association between periodontitis and diabetes.
| INTRODUCTION
The interplay between periodontal disease and diabetes has long been reported, with evidence showing complex interactions between these two distinct pathologies. Epidemiological studies and clinical trials had shown that diabetes patients with difficulties in controlling serum glucose levels are more likely to suffer from periodontitis, compared with those having sufficient diabetes control and people without diabetes, while periodontitis affects the management of diabetes control.
Alongside the clinical evidence of this association, studies ventured to understand the biological mechanism which links the periodontal condition and diabetes.
In 2013, in the frame of the EFP workshop, four comprehensive reviews were published under the title "Diabetes and periodontal diseases." One of the articles was by Taylor, Preshaw, and Lalla (2013) reviewed the biological plausibility of the bidirectional association between periodontitis and diabetes and included a literature search until May 2012.
The aim of this study is to provide an update on the biological plausibility of the associations between periodontitis and diabetes. This study is based on Taylor et al. (2013) , and includes additional publications from 2012 to November 2016, with information that may alter or add to the conclusions of the consensuses report (Chapple & Genco, 2013) .
The biological plausibility of the association between periodontitis and diabetes was analysed by addressing the following topics:
1. Biological plausibility of the increased in severity of periodontitis in diabetes patients.
2.
Biological plausibility of the effect of periodontitis on diabetes control.
3.
Biological plausibility of the effect of treatment of periodontitis on diabetes control. 
| METHODS

nisms OR pathogenesis OR infection OR pathogen OR P. gingivalis]).
The search resulted in total of 2,560 articles. Since Taylor et al. 
| RESULTS
| Biological plausibility of increase in severity of periodontitis in patients with diabetes
Studies that examined the periodontal status in subjects with diabetes (human, animals and in vitro models) were included.
Data regarding the biological mechanism of increased severity of Taylor et al. (2013) conclude (from Table 1 of their review) that it is apparent that the presence of diabetes (type 1 diabetes mellitus
| Microbial factors
[T1DM] or type 2 diabetes mellitus [T2DM]) has no significant effect on the composition of the periodontal microbiota. Furthermore, the level of glycemic control in people with diabetes also does not significantly influence the composition of the subgingival biofilm. Recent studies that explored the possible association between the compositions of the periodontal flora in patients with diabetes using 16S rRNA Sequencing (Casarin et al., 2013; Zhou et al., 2013) found evidence which may indicate a difference in microbial composition in patients with diabetes mellitus (DM). Recent studies based on PCR technology also show a shift in microbial composition in DM (Aemaimanan, Amimanan, & Taweechaisupapong, 2013; Castrillon et al., 2015; Demmer et al., 2015; Merchant et al., 2014; Sakalauskiene et al., 2014) . Furthermore, three of these studies demonstrated this shift only in poorly controlled diabetic patients (Aemaimanan et al., 2013; Merchant et al., 2014; Sakalauskiene et al., 2014) . Still, the above data do not provide solid evidence of causal relationship between poorly controlled DM and periodontal microbial dysbiosis, and the available date derived from cross-sectional studies. Further studies (human
Clinical relevance
Scientific rational for the study: Our aim was to look for the current evidence of biological mechanism that may link periodontitis to diabetes and vice versa, by updating the review of Taylor et al. (2013) .
Principal findings:
Clinical and animal studies found elevated gingival levels of IL1-β, TNF-α, IL-6, RANKL/OPG and oxygen metabolites in poorly controlled diabetes, which may lead to aggravation of the periodontal status. On the other hand, individuals with diabetes and periodontitis exhibit high levels of circulating TNF-α, CRP and mediators of oxidative stress that may lead to difficulties in controlling diabetes. However, successful periodontal treatment reduces their levels.
Practical implications: Our knowledge regarding the biological factors which links periodontitis and diabetes are important to periodontists and diabetologists. Understanding the interplay between these diseases may help for establishing early intervention guidelines for reducing periodontal as well as diabetes complications.
cohorts, animal studies and in vitro models) are required to substantiate such relationship. Taylor et al. (2013) conclude (from Table 2 of their review) that there is good evidence for elevated levels of IL-1β, IL-6 and RANKL/OPG ratios in patients with diabetes and periodontitis as compared to patients with periodontitis alone as well as a quantitative relationship between these cytokines and glycemic control. The majority of studies relate to T2DM but changes in IL-1β may be important in T1DM also. Substantial evidence from animal studies supports a role for TNF-α in periodontitis in animal diabetes models (both T1DM and T2DM), although human clinical studies regarding the role of TNF-α are inconclusive. More recent evidence from human (Table 1b) , animal and cell culture (Table 1c ) studies strongly suggest that diabetes and hyperglycaemic conditions induced a hyper-inflammatory state in the infected periodontal tissues. The most abundant data are available regarding increased levels of gingival crevicular fluid (GCF) TNF-α, IL-6 and IL-1β in diabetes (Bastos et al., 2012; Chang, Tsai, Chong, & Kao, 2014; Duarte et al., 2014; Huang et al., 2015; Javed, Al-Daghri, Wang, Wang, & Al-Hezaimi, 2014; Jiang et al., 2012 Jiang et al., , 2013 Shikama, Kudo, Ishimaru, & Funaki, 2015; Wu, Liu, Zhang, & Shu, 2014; Yang et al., 2014) . Other pro-inflammatory factors and periodontal tissue cell function were also found to be associated with diabetes condition, and include substance-P (Ozturk, Bilgici, Odyakmaz, & Konas, 2012) , iNOS (Shaker, Ghallab, Hamdy, & Sayed, 2013) , resistin (Gokhale et al., 2014) and other various pro-inflammatory cytokines.
| Cytokines and adipokines
Furthermore, studies have shown that hyperglycaemic state can lead to increased expression of innate immunity receptors, such as TLR2 and TLR4 (Jiang et al., 2012; Yang et al., 2014) . Taken the above data together, the elevated levels of pro-inflammatory factors in the periodontal tissues of DM patients may have a role in the observed increased periodontal destruction. Taylor et al. (2013) Table 1c ). These alterations in PDL fibroblast functions may play a role in the pathogenesis of DM-aggravation of periodontitis, in addition to the classic inflammatory cells.
| Immune cell function
3.1.4 | Hyperglycaemia, advanced glycation end products (AGEs) and their receptor (RAGE) Taylor et al. (2013) 
in detail evidence that shows elevated levels of AGEs and RAGE in gingival tissues of periodontitis patients, which may contribute to the biological plausibility of increased severity of periodontitis in patients with diabetes. Animal studies demonstrated that blocking RAGE in animals with diabetes decrease the levels of inflammatory cytokines and MMPs in gingival tissues as well as suppressed experimental bone loss (Lalla et al., 2000) . More recent evidence supports this finding by
showing that breaking AGEs in rats with diabetes reduced gingival tissue levels of TNF-α . These findings demonstrated that AGE-RAGE interaction may lead to the exaggerated inflammatory response and periodontal tissue destruction in diabetes. Recent data derived from human, animal and cell culture experiments support the above conclusion of Taylor et al. (2013) and suggest additional DM factors that may affect the state of inflammation in the periodontal tissues: Bastos et al. (2012) found positive associations between systemic levels of plasma lipid profile (measured as lipid peroxidation, LPO) and the levels of inflammatory cytokines in the GCF. In fact,
LPOs were directly related to the severity of clinical measures of periodontal disease. GCF resistin levels were also found to positively correlate with periodontal parameters and HbA1c (Gokhale et al., 2014) . Mohamed et al. (2015) found that gastric inhibitory polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon were significantly upregulated in diabetic patients with chronic periodontitis compared with diabetes patients only. The same study found that the number of sites with pocket depth >4 mm correlated positively with GIP. Taylor et al. (2013) conclude from their review that evidence from clinical studies related to mediators of bone resorption (e.g., RANKL/ OPG), as well as relevant animal models strongly suggest that altered alveolar bone homeostasis is an important pathway of periodontal pathogenesis in diabetes, and there is evidence that this pathway may be important in both T1DM and T2DM. These interactions were recently re-reviewed by Wu, Xiao, & Graves (2015) who detailed evidence which associate hyperglycaemia and disrupted bone homeostasis.
| Hyperglycaemia and alveolar bone homeostasis
In human mesenchymal stem cells, AGEs suppress the osteogenic differentiation of both cell types by increasing TGF-β expression (Notsu et al., 2014) . Also, increased fatty acid levels in patients with diabetes induce osteoclastogenesis via TNF-α (Drosatos-Tampakaki et al., 2014). In contrast, Reyes-Garcia et al. (2013) in a cohort study which includes 133 subjects, showed that markers of bone resorption (Carboxy-terminal telopeptide, CTX and Tartrate-resistant acid phosphatase 5b, TRAP5b) were decreased in people with T2DM. In animals, Alblowi et al. (2013) , showed a TNF-α dependent increase in chemokine expression, which led to increased osteoclast activity in animals with diabetes. Results of in vitro experiments with primary human and mouse osteoclast cells suggest that hyperglycaemia may lead to their increased formation (Catalfamo, Britten et al., 2013) .
Overall, the data support the concept which states that changes in the RANKL/OPG axis and an inflammatory state in diabetes play an important role in alveolar bone loss during periodontitis in individuals with diabetes.
| Biological plausibility of the effect of periodontitis on diabetes control
Although human studies suggest that diabetes control (measured as serum HbA1c or glucose levels) is affected by periodontitis, there is scarce mechanistic evidence that supports its biological plausibility (Table 2 , Figure 2 ). The effect of periodontitis on diabetes control may originate from seepage of periodontal inflammation mediators into the serum and cause systemic inflammatory state. Potential key factors that are considered as mediators between periodontal inflammation and glucose homeostasis include IL-6, TNF-α, and CRP as well as oxygen radicals. All these mediators are implicated with impaired insulin signalling and resistance (Allen, Matthews, O'Halloran, Griffiths, & Chapple, 2011; Hotamisligil, 2000; Rotter, Nagaev, & Smith, 2003) .
This issue was discussed by Taylor et al. (2013) -but not in a separate Table. In the current update, we summarized the publications that were discussed by Taylor et al. (2013) , and included an update until November 2016.
As can be seen from Table 2 , the data from human studies show conflicting evidence of the role of circulating levels of inflammatory mediators (CRP, TNF-α and IL-6) in patients with both periodontitis and diabetes. Many studies failed to show an association (Dag, Firat, Arikan, Kadiroglu, & Kaplan, 2009; Kardesler, Buduneli, Cetinkalp, & Kinane, 2010; Longo et al., 2014; Takeda et al., 2006) , while other showed increased serum levels of these inflammatory mediators in patients with diabetes and untreated periodontitis (Allen et al., 2011; Andriankaja et al., 2009; Bastos et al., 2012; Chen et al., 2010; Choi et al., 2014; Demmer et al., 2010; Ozturk et al., 2012 ; Poplawska-Kita , 2014) . Some of these studies found correlation between controlling sugar levels and circulation inflammatory mediators (Poplawska-Kita et al., 2014) . Some studies also suggest that increased systemic oxidative stress due to periodontal infection may activate systemic pro-inflammatory pathways which could influence diabetes (Allen et al., 2011; Bastos et al., 2012) . The available data suggest a possible association between untreated periodontitis and control of diabetes, but more research is needed to investigate this issue further.
There is almost no evidence from animal models regarding the mechanism by which periodontal inflammation affects glucose homeostasis in DM patients. Li et al. (2013) showed in mice with diabetes that although oral infection with P. gingivalis influences serum TNF-α, the onset or severity of diabetes was not affected by the infection. More animal studies may shed light on this unresolved issue.
| Biological plausibility of the effect of treatment of periodontitis on diabetes control
Several meta-analyses concluded that there is evidence that periodontal treatment has a modest effect on glycaemic control in in- Figure 3 ). The review by Taylor et al. (2013) discussed the biological plausibility of this effect in the frame of the previous section, that is biological plausibility of the effect of periodontitis on diabetes control. However, the importance of a possible effect of periodontal treatment on diabetes control, and the above existing clinical evidence on HbA1c levels led us to examine the biological plausibility for this effect separately. Table 3 summarizes the relevant literature from Taylor et al. (2013) with an update until November 2016.
There is limited and conflicting evidence from human studies on the impact of circulating inflammatory mediator's levels in individuals with diabetes following periodontal treatment. A systematic review and meta-analysis that summarized the literature up to November 2013 (Artese et al., 2015) found that periodontal therapy reduces serum TNF-α and CRP levels in T2DM individuals. In their analysis, Artese et al. included three studies with information regarding TNF-α and five studies with information regarding CRP.
More recent data (from 2013 until 2016) also support the conclusions of Artese et al. (Table 3 ). The decrease of inflammatory burden has important implications regarding metabolic control and can partially explain the mechanism which links periodontitis and an increased risk for complications in T2DM patients. In addition to TNF-α and CRP, reduction in serum visfatin may also link periodontal therapy and improvement in metabolic control (Wu, Chen, Wei, Luo, & Yan, 2015) .
However, due to the limited number of studies that were included in the systematic analysis, more research is needed to establish the biological plausibility of periodontal intervention and its effect on diabetes control.
| CONCLUSIONS
1. The effect of T2DM on the inflammatory status of the periodontal tissue is well established. Animal and cell culture studies show clearly that hyperglycaemia conditions augment the pro-inflammatory response in the periodontal environment, and human studies support this mechanism. Diabetes condition affects many biological properties, including cell functions (leucocytes, fibroblasts and osteoclasts), pro-inflammatory cytokines and alteration in RANKL/OPG ratio. There is evidence to support the hypothesis F I G U R E 3 Potential mechanisms which enable periodontal intervention to affect diabetes control in diabetes patients with periodontitis that the above effects are mediated by hyperglycaemia and AGEs which accumulated in the periodontal tissues. The effect of diabetes on the microbial composition is still unclear, although new emerging technologies showed differences in the composition of the periodontal flora in DM versus healthy patients, which potentially can also play a role in the aggravation of periodontitis in poorly controlled DM patients. However, the difference in composition may merely be related to changes in the ecology of the subgingival niche and as such a consequence rather than a cause 2. There is moderate level of evidence to support biological mechanisms mediating the effect of periodontitis on diabetes control.
Most of the studies are merely cross-sectional and show that circulating pro-inflammatory mediators are elevated in patients with DM and periodontitis, particularly TNF-α, CRP and mediators of oxidative stress. These pro-inflammatory mediators may affect diabetes control in DM patients. Unfortunately, there is no animal data to support this possibility.
3.
There is moderate level of evidence from several controlled human studies which show that periodontal treatment may affect the levels of circulating mediators that are associated with glucose homeostasis in DM patients.
4.
More human studies are needed to explore the effects of periodontal inflammation and periodontal treatment in DM patients. Such studies would benefit greatly by including serum inflammatory mediators levels analysis, which can contribute to the understanding of the biological mechanisms. More animal studies are needed to explore the biological effect of periodontitis on DM models. Human longitudinal studies are needed to enrich our knowledge regarding these topics, due to the fact that there are limited number of parameters that were studied to date.
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